These results suggest the presence of PKCδ/HIF-1α/TGFβ1-mediated immune suppression in CESC, LUAD, and PAAD, while COAD cancers do not result in this immune suppression. This evidence concerns the gene PRKCD and pancreatic adenocarcinoma.